Stockreport

HOOKIPA Pharma Announces Enrollment Completion of Phase 1b Clinical Trial Evaluating HB-500 for the Treatment of HIV

HOOKIPA Pharma Inc.  (HOOK) 
Last hookipa pharma inc. earnings: 3/19 07:00 am Check Earnings Report
PDF HB-500 is a next-generation therapeutic vaccine being developed in collaboration with Gilead Sciences, Inc. (Gilead) as a potential component of a curative regimen for h [Read more]